The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The COVID-19 Pandemic & the ACR’s Response

The COVID-19 Pandemic & the ACR’s Response

June 15, 2020 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Shannon Strange

Shannon Strange

The ACR has been working on many levels to assist the rheumatology community during the COVID-19 pandemic, and we are focusing our efforts on areas critical for rheumatologists and rheumatology professionals, practices and patients. Because the pandemic poses many clinical and economic challenges, the ACR will continue to monitor this fast-paced, ever-changing situation and provide updates as additional information becomes available.

You Might Also Like
  • EULAR & ACR COVID-19 Recommendations: How to Manage Patients During the COVID-19 Pandemic
  • The COVID-19 Crisis: Uncharted Waters & the ACR’s Response
  • The ACR on Air Podcast’s COVID-19 Series
Explore This Issue
June 2020
Also By This Author
  • AMA Workshop Focuses on Alternative Payment Models

Several pages on the ACR website are dedicated to the COVID-19 pandemic and how the situation continues to affect the rheumatology community. Also, information has been posted about the work of two ACR task forces formed to explore ways to support rheumatology professionals and your patients during this time.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Clinical Guidance Task Force has developed and published clinical guidance for the care of adult patients with rheumatic diseases during the COVID-19 pandemic, and the Practice and Advocacy Task Force has created and updated several guidance documents, including approaches to drug shortages, support for telehealth, information about federal stimulus relief aid, guidance for infusions and more.

The ACR is also aware that the recent shift in ways of working, connecting and learning has challenged organizations to adapt to a level of change and uncertainty that is truly unprecedented. Thus, the ACR staff and volunteers are planning the next annual meeting, ACR Convergence 2020, with the safety and well-being of our members, attendees, exhibitors, supporters and staff at the forefront.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Visit Announcements to learn more about the ACR’s efforts during this unprecedented time.

Filed Under: From the College Tagged With: ACR Convergence 2020, Clinical Guidance Task Force, COVID-19, Practice and Advocacy Task ForceIssue: June 2020

You Might Also Like:
  • EULAR & ACR COVID-19 Recommendations: How to Manage Patients During the COVID-19 Pandemic
  • The COVID-19 Crisis: Uncharted Waters & the ACR’s Response
  • The ACR on Air Podcast’s COVID-19 Series
  • Join the ACR COVID-19 Clinical Guidance Town Hall: May 6

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)